Objective: Previous studies have used acetylcholinesterase (AChE) histochemistry to identify cholinergic nerves in the heart, but this enzyme is not a selective marker for cholinergic neurons. This study maps cholinergic innervation of guinea pig heart using a new antibody to the human high-affinity choline transporter (CHT), which is present only in cholinergic nerves. Methods: Immunohistochemistry was used to localize CHTs in frozen and paraffin sections of heart and whole mount preparations of atrial ganglionated nerve plexus. AChE-positive nerve fibers were identified in sections from separate hearts for comparison. Results: Control experiments established that the antibody to human CHT selectively labeled cholinergic neurons in the guinea pig. CHT-immunoreactive nerve fibers and AChE-positive nerves were very abundant in the sinus and AV nodes, bundle of His, and bundle branches. Both markers also delineated a distinct nerve tract in the posterior wall of the right atrium. AChE-positive nerve fibers were more abundant than CHT-immunoreactive nerves in working atrial and ventricular myocardium. CHT-immunoreactive nerves were rarely observed in left ventricular free wall. Both markers were associated with numerous parasympathetic ganglia that were distributed along the posterior atrial walls and within the interatrial septum, including the region of the AV node. Conclusions: Comparison of labeling patterns for CHT and AChE suggests that AChE histochemistry overestimates the density of cholinergic innervation in the heart. The distribution of CHT-immunoreactive nerve fibers and parasympathetic ganglia in the guinea pig heart suggests that heart rate, conduction velocity, and automaticity are precisely regulated by cholinergic innervation. In contrast, the paucity of CHT-immunoreactive nerve fibers in left ventricular myocardium implies that vagal efferent input has little or no direct influence on ventricular contractile function in the guinea pig.

No description available.

No description available.

No description available.

Switchable supercapacitors (SCs) enable a reversible electrically-driven uptake/release of bioactive ions by polarizing porous carbon electrodes. Herein we demonstrate the first example of a bioactive ion-based switchable supercapacitor. Based on choline chloride and porous carbons we unravel the mechanism of physisorption vs. electrosorption by nuclear magnetic resonance, Raman, and impedance spectroscopy. Weak physisorption facilitates electrically-driven electrolyte depletion enabling the controllable uptake/release of electrolyte ions. A new 4-terminal device is proposed, with a main capacitor and a detective capacitor for monitoring bioactive ion adsorption in situ. Ion-concentration control in printed choline-based switchable SCs realizes switching down to 8.3 % residual capacitance. The exploration of adsorption mechanisms in printable microdevices will open an avenue of manipulating bioactive ions for the application of drug delivery, neuromodulation, or neuromorphic devices.

Os desafios atuais no desenvolvimento de biossensores abrangem diversos aspectos, tais como a necessidade de se aperfeiçoar a interface de contato entre o substrato e o material biológico, a eficiência de transdução do sinal químico em um sinal mensurável, o tempo de resposta, a compatibilidade dos biossensores com matrizes biológicas e a integração de diferentes elementos de reconhecimento biológico em um único dispositivo, visando a detecção de distintos analitos. Nesse contexto, o desenvolvimento da nanociência tem criado recursos bastante atraentes para otimizar os aspectos descritos acima. O presente trabalho apresenta, portanto, estudos realizados para a construção de mediadores nanoestruturados que possam operar de maneira mais eficiente que os correspondentes materiais maciços (sistemas não-nanoestruturados). Em uma das abordagens utilizadas, um mediador híbrido de hexacianoferrato de cobre/polipirrol (CuHCNFe/Ppy) teve suas propriedades eletroquímicas aliadas às propriedades morfológicas e eletrônicas de um feltro revestido com nanotubos de carbono do tipo \"cup-stacked\" (feltro/NTCCS) para o desenvolvimento de um sensor de H2O2. O feltro/NTCCS é uma malha hidrofílica condutora que permite uma dispersão bastante uniforme do mediador híbrido. Essa característica, aliada ao aumento da área eletroativa e à interação eletrônica existente entre o CuHCNFe/PPy e os nanotubos de carbono criaram uma plataforma favorável para a construção de um biossensor de glicose. Em uma segunda estratégia, esferas de poliestireno com diâmetros de 300, 460, 600 e 800 nm foram utilizadas como molde para a formação de filmes de CuHCNFe/PPy macroporosos. Os distintos mediadores foram aplicados na detecção de H2O2 com o intuito de se correlacionar a importância do tamanho do poro com o desempenho analítico obtido. Diferentemente do esperado, os mediadores maciços e porosos apresentaram desempenhos analíticos bastante similares, o que levou a uma consideração das propriedades termodinâmicas de superfícies curvas, da molhabilidade de materiais porosos e da influência da cinética eletroquímica na utilização de sistemas porosos. Tais plataformas também foram aplicadas com sucesso na construção de biossensores de glicose e de colina. Por fim, foi possível sintetizar mediadores nanoestruturados através da imobilização de camadas de azul da Prússia e de CuHCNFe dentro das cavidades de filmes de TiO2 mesoporosos (13, 20 e 40 nm de diâmetro). Os resultados obtidos demonstraram a possibilidade de se modular o desempenho dos sensores de H2O2 em função do diâmetro dos poros e da quantidade de mediador imobilizado. A união dos resultados analíticos obtidos com os dados de microscopia eletrônica de varredura possibilitou observar a importância do efeito de confinamento no desempenho dos mediadores. Além disso, dados espectroscópicos na região do visível foram fundamentais para relacionar a presença de defeitos estruturais com a reatividade do material. No fim, tais plataformas foram utilizadas para a formulação de biossensores de colina. / Nowadays, the challenges in the development of biosensors cover various aspects such as the need to improve the interface between the substrate and the biological material, the efficiency of the chemical signal transduction in a measurable one, the response time, the compatibility with biological matrices and the integration of different biological recognition elements in a single device, in order to perform detections of different analytes. In this context, the development of nanoscience has created very attractive features to optimize the aspects described above. Consequently, the present work studies the build up of nanostructured transducers that can operate more efficiently than the corresponding bulk materials (systems non-nanostructured). In one of the approaches used, a hybrid transducer consisting of copper hexacyanoferrate/polypyrrole (CuHCNFe/Ppy) had its electrochemical properties combined with the morphological and electronic properties of a felt decorated with cup-stacked type carbon nanotubes (felt/CSCNT) for development of a H2O2 sensor. Felt/CSCNT is a hydrophilic conductive mesh that allows a uniform dispersion of the hybrid transducer. This feature, coupled with the improvement of electroactive surface and with the electronic interaction among the CuHCNFe/Ppy and carbon nanotubes have created a favorable platform for the construction of a glucose biosensor. In a second strategy, polystyrene spheres with diameters of 300, 460, 600 and 800 nm were used as templates for the formation of macroporous CuHCNFe/Ppy films. The transducers were used to detect H2O2 in order to correlate the importance of pore size with the obtained analytical performance. Unlike expected, porous and bulk transducers presented very similar analytical performances, which led to a consideration of the thermodynamic properties of curved surfaces, the wettability of porous materials and the influence of electrochemical kinetics during the use of porous systems. Such platforms have also been successfully applied in the preparation of glucose and choline biosensors. Finally, it was possible to synthesize nanostructured transducers through the immobilization of Prussian blue layers and CuHCNFe inside the cavities of mesoporous TiO2 films (pore diameters of 13, 20 and 40 nm). The obtained results demonstrated the possibility of modulating the performance of H2O2 sensors according to the pore diameter and the amount of immobilized transducer. The union of the obtained analytical results with scanning electron microscopy data showed the importance of confinement effect on the transducers performances. In addition, spectroscopic data in the visible region were essential to correlate the presence of structural defects with the material reactivity. In the end, these platforms were used for the formulation of choline biosensors.

Im Rahmen dieser Arbeit wurde der Einfluss des GPIIb/IIIa- Antagonisten Tirofiban auf die Vollblut-Konzentration des Phospholipase D Metaboliten Cholin (2- hydroxyethyltrimethylammonium, "whole blood cholin", WBCHO) bei Patienten mit akutem Koronarsyndrom untersucht. Die Phospholipase D hat eine Schlüsselfunktion bei der Destabilisierung atherosklerostischer Plaques, Aktivierung von Thrombozyten und Sekretion von Matrixmetalloproteinasen durch Makrophagen. Als Analyseverfahren für Cholin wurde die Hochleistungsflüssigkeits-Chromatographie (HPLC) in Verbindung mit der Massenspektrometrie (MS) eingesetzt. Die Klassifikation der Patienten erfolgte nach den aktuellen Richtlinien der European Society of Cardiology (ESC) und des American College of Cardiology (ACC) für das akute Koronarsyndrom. Aus einem Kollektiv von 342 Patienten wurden 32 Patienten mit akutem Koronarsyndrom in diese Studie aufgenommen, in zwei Gruppen mit jeweils 16 Patienten mittels matched pairs Technik unterteilt und analysiert. Eine Gruppe erhielt zusätzlich zur Standard- Therapie Tirofiban. Es wurden Blutabnahmen bei Aufnahme, nach 3-6 Stunden und nach 12-24 Stunden gewonnen. Hieraus wurden Troponin I und T, Myoglobin, Kreatinkinase Isoenzym MB, sowie Vollblut-Cholin bestimmt. Es gab einen signifikanten Verlauf der WBCHO- Konzentration (p = 0,006) in der mit Tirofiban behandelten Gruppe im Gegensatz zur Gruppe die nur die Standardtherapie erhielt (p = 0,174). Für den Verlauf der Standardmarker (Myoglobin, Kreatinkinase, Troponin I und T), wurde keine signifikante Beeinflussung durch die Therapie mit Tirofiban nachgewiesen. Im Vergleich zu Troponin I und T, Myoglobin und Kreatinkinase hatte WBCHO das zeitlich früheste Maximum. WBCHO könnte als Markersubstanz der Phospholipase D Aktivität zusätzliche Informationen über die Möglichkeit einer Destabilisierung einer atherosklerotischen Plaque bei Patienten mit akutem Koronarsyndrom geben. Dies könnte in Kombination mit anderen Markern eine verbesserte Risikostratifizierung in der Frühphase des akuten Koronarsyndroms ermöglichen. Zusätzlich scheint ein Monitoring der Tirofiban Therapie durch die WBCHO Konzentration möglich zu sein. / This research work deals with the measurement of the phospholipase D metabolite choline in patients with acute coronary syndrome (ACS) undergoing GPIIb/IIIa antagonist therapy. The influence of GPIIb/IIIa antagonists on concentration levels of the PLD metabolite 2- hydroxyethyltrimethylammonium in blood (whole blood choline, WBCHO) was studied. The activation of phospholipase D (PLD) has a key function in plaque destabilisation, activation of platelets and secretion of matrixmetalloproteinases by macrophages. For the detection of the PLD metabolite WBCHO high pressure liquid chromatography (HPLC) with a mass spectrometer (MS) was used. The classification of patients was performed according to the current guidelines of the European Society of Cardiology (ESC) and the American College of Cardiology (ACC). 32 patients with ACS out of a 342 patient study were included and analysed by matched pairs technique as two groups with 16 patients. One group was treated with Tirofiban (aggrastrat) in addition to standard therapy. Blood samples were taken at admission, after 3-6 hours and after 12-24 hours and in addition to the troponines, myoglobin and creatinkinase Isoenzyme MB, whole blood choline was analyzed. There was a significant (p = 0,006) decrease of WBCHO level in the group treated with Tirofiban in contrast to the reference group with no significant decrease (p = 0,174). The levels of conventional markers as troponin I and T, CK-MB mass and myoglobin had no significant changes in relationship to the Tirofiban therapy. WBCHO had the earliest maximum in contrast to all other markers. We concluded that WBCHO can be used as an additional early risk marker in ACS. Since GPIIb/IIIa- antagonist- therapy may influence WBCHO level, WBCHO has potential to be used for monitoring of therapy.

Diss. (sammanfattning) Linköping : Linköpings universitet, 2010. / Härtill 6 uppsatser.

Os desafios atuais no desenvolvimento de biossensores abrangem diversos aspectos, tais como a necessidade de se aperfeiçoar a interface de contato entre o substrato e o material biológico, a eficiência de transdução do sinal químico em um sinal mensurável, o tempo de resposta, a compatibilidade dos biossensores com matrizes biológicas e a integração de diferentes elementos de reconhecimento biológico em um único dispositivo, visando a detecção de distintos analitos. Nesse contexto, o desenvolvimento da nanociência tem criado recursos bastante atraentes para otimizar os aspectos descritos acima. O presente trabalho apresenta, portanto, estudos realizados para a construção de mediadores nanoestruturados que possam operar de maneira mais eficiente que os correspondentes materiais maciços (sistemas não-nanoestruturados). Em uma das abordagens utilizadas, um mediador híbrido de hexacianoferrato de cobre/polipirrol (CuHCNFe/Ppy) teve suas propriedades eletroquímicas aliadas às propriedades morfológicas e eletrônicas de um feltro revestido com nanotubos de carbono do tipo \"cup-stacked\" (feltro/NTCCS) para o desenvolvimento de um sensor de H2O2. O feltro/NTCCS é uma malha hidrofílica condutora que permite uma dispersão bastante uniforme do mediador híbrido. Essa característica, aliada ao aumento da área eletroativa e à interação eletrônica existente entre o CuHCNFe/PPy e os nanotubos de carbono criaram uma plataforma favorável para a construção de um biossensor de glicose. Em uma segunda estratégia, esferas de poliestireno com diâmetros de 300, 460, 600 e 800 nm foram utilizadas como molde para a formação de filmes de CuHCNFe/PPy macroporosos. Os distintos mediadores foram aplicados na detecção de H2O2 com o intuito de se correlacionar a importância do tamanho do poro com o desempenho analítico obtido. Diferentemente do esperado, os mediadores maciços e porosos apresentaram desempenhos analíticos bastante similares, o que levou a uma consideração das propriedades termodinâmicas de superfícies curvas, da molhabilidade de materiais porosos e da influência da cinética eletroquímica na utilização de sistemas porosos. Tais plataformas também foram aplicadas com sucesso na construção de biossensores de glicose e de colina. Por fim, foi possível sintetizar mediadores nanoestruturados através da imobilização de camadas de azul da Prússia e de CuHCNFe dentro das cavidades de filmes de TiO2 mesoporosos (13, 20 e 40 nm de diâmetro). Os resultados obtidos demonstraram a possibilidade de se modular o desempenho dos sensores de H2O2 em função do diâmetro dos poros e da quantidade de mediador imobilizado. A união dos resultados analíticos obtidos com os dados de microscopia eletrônica de varredura possibilitou observar a importância do efeito de confinamento no desempenho dos mediadores. Além disso, dados espectroscópicos na região do visível foram fundamentais para relacionar a presença de defeitos estruturais com a reatividade do material. No fim, tais plataformas foram utilizadas para a formulação de biossensores de colina. / Nowadays, the challenges in the development of biosensors cover various aspects such as the need to improve the interface between the substrate and the biological material, the efficiency of the chemical signal transduction in a measurable one, the response time, the compatibility with biological matrices and the integration of different biological recognition elements in a single device, in order to perform detections of different analytes. In this context, the development of nanoscience has created very attractive features to optimize the aspects described above. Consequently, the present work studies the build up of nanostructured transducers that can operate more efficiently than the corresponding bulk materials (systems non-nanostructured). In one of the approaches used, a hybrid transducer consisting of copper hexacyanoferrate/polypyrrole (CuHCNFe/Ppy) had its electrochemical properties combined with the morphological and electronic properties of a felt decorated with cup-stacked type carbon nanotubes (felt/CSCNT) for development of a H2O2 sensor. Felt/CSCNT is a hydrophilic conductive mesh that allows a uniform dispersion of the hybrid transducer. This feature, coupled with the improvement of electroactive surface and with the electronic interaction among the CuHCNFe/Ppy and carbon nanotubes have created a favorable platform for the construction of a glucose biosensor. In a second strategy, polystyrene spheres with diameters of 300, 460, 600 and 800 nm were used as templates for the formation of macroporous CuHCNFe/Ppy films. The transducers were used to detect H2O2 in order to correlate the importance of pore size with the obtained analytical performance. Unlike expected, porous and bulk transducers presented very similar analytical performances, which led to a consideration of the thermodynamic properties of curved surfaces, the wettability of porous materials and the influence of electrochemical kinetics during the use of porous systems. Such platforms have also been successfully applied in the preparation of glucose and choline biosensors. Finally, it was possible to synthesize nanostructured transducers through the immobilization of Prussian blue layers and CuHCNFe inside the cavities of mesoporous TiO2 films (pore diameters of 13, 20 and 40 nm). The obtained results demonstrated the possibility of modulating the performance of H2O2 sensors according to the pore diameter and the amount of immobilized transducer. The union of the obtained analytical results with scanning electron microscopy data showed the importance of confinement effect on the transducers performances. In addition, spectroscopic data in the visible region were essential to correlate the presence of structural defects with the material reactivity. In the end, these platforms were used for the formulation of choline biosensors.

Neurodegenerative diseases are becoming increasingly prevalent due to the ageing population, and are among the major contributors to disability and disease worldwide. The identification of the gene defects responsible for many of these conditions has played a major role in our understanding of the pathogenic processes involved, and provided opportunity to develop targeted treatment strategies. Cholinergic neurotransmission supports a wide range of physiological and behavioural processes and its dysfunction of cholinergic signalling has been associated with a number of disorders, including myasthenias, cardiovascular disease(1), attention-deficit hyperactivity disorder (ADHD) (2), Alzheimer’s disease (ADi), schizophrenia, addiction(3), and depression(4). SLC5A7 encodes the Na+/Cl- dependent, high-affinity choline transporter (CHT) which represents the rate limiting step in acetylcholine (Ach) synthesis and is critical for normal cholinergic signalling. The work in this thesis details two new inherited disorders, caused by distinct pathogenic disease mechanisms, associated with novel SLC5A7 mutations. Chapter three documents the discovery of two autosomal-dominantly acting SLC5A7/CHT mutations associated with adult onset motor neurone disorders. Initially we identified a frameshift mutation that results in premature truncation of the transporter protein in a large Welsh kindred affected with distal hereditary motor neuropathy type VII (dHMN-VII), in which neurodegeneration and muscle paresis is largely restricted to the distal limb muscles and vocal cords. The mutation responsible results in the dominant-negative interference of the mutant molecule with function of the wild type choline transporter, resulting in significantly reduced (although not completely abolished) transporter activity. This finding is further evidenced by the discovery of a second dHMN family associated with a distinct frameshift SLC5A7 mutation indicative of a similar dominant-negative disease mechanism. Together these findings corroborate a dominant-negative disease mechanism arising from C-terminal truncating SLC5A7 mutations associated with dHMN, and provide further insight into the role of aberrant choline transporter function in neurological disease. Chapter four describes N-terminal missense mutations located in the transmembrane spanning region of SLC5A7/CHT, associated with a severe infantile neuromuscular disorder characterised by predominantly central hypotonia and developmental delay. The phenotypic effects of these mutations are likely to result from the near abolition of CHT-mediated choline transport in homozygous individuals, and are in keeping with those observed in CHT knock-out mouse models(5). The development of a mouse model of the human motor neurone disease arising from SLC5A7 frameshift mutations should allow for further investigation of the mechanism by which truncated CHT leads to the dHMN phenotype. Chapter 5 details treatment hypotheses for dHMN, as well as the generation of a patient-specific knock-in mouse model carrying an Slc5a7 mutation orthologous to that identified in dHMN-VII families in chapter 3, and results from preliminary neurological phenotyping of the mouse model. This model will be crucially important for the exploration of treatment options in dHMN-VII motor neurone disease as a prelude to clinical trials in humans.